Y-Intercept (HK)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.6M Buy
16,330
+2,665
+20% +$1.49M 0.17% 124
2026
Q1
$7.68M Buy
13,665
+8,181
+149% +$5.25M 0.15% 179
2025
Q4
$3.71M Buy
5,484
+4,437
+424% +$3.02M 0.08% 330
2025
Q3
$669K Buy
+1,047
New +$636K 0.02% 1156
2025
Q2
Sell
-1,609
Closed -$676K 1796
2025
Q1
$676K Sell
1,609
-7,523
-82% -$3.27M 0.05% 568
2024
Q4
$3.78M Buy
9,132
+6,633
+265% +$2.91M 0.25% 90
2024
Q3
$1.26M Buy
+2,499
New +$1.21M 0.08% 349
2024
Q2
Sell
-2,548
Closed -$1.38M 1617
2024
Q1
$1.38M Buy
+2,548
New +$1.39M 0.1% 268
2023
Q4
Sell
-6,176
Closed -$2.7M 1414
2023
Q3
$2.7M Buy
+6,176
New +$3.08M 0.26% 86
2023
Q1
Sell
-6,642
Closed -$2.71M 1334
2022
Q4
$2.71M Buy
6,642
+5,171
+352% +$2.01M 0.4% 25
2022
Q3
$479K Sell
1,471
-3,585
-71% -$1.32M 0.05% 555
2022
Q2
$1.77M Buy
+5,056
New +$2.06M 0.23% 108
2021
Q4
Sell
-2,892
Closed -$1.8M 707
2021
Q3
$1.8M Buy
+2,892
New +$1.94M 0.33% 80
2021
Q2
Sell
-742
Closed -$353K 744
2021
Q1
$353K Buy
+742
New +$372K 0.09% 344

Other funds holding IDXX

Y-Intercept (HK)'s IDXX Position: Q2 2026 in Review

Y-Intercept (HK) increased its Idexx Laboratories (IDXX) stake by 20% in Q2 2026, buying an estimated $1.49M and bringing the position to 16,330 shares worth $8.6M. The position accounts for 0.17% of the portfolio, ranked #124.

Y-Intercept (HK) first reported a position in IDXX in Q1 2021 and has held it in 14 quarters since. 235 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Y-Intercept (HK) held 16,330 shares of Idexx Laboratories worth $8.6M as of Q2 2026.
  • Y-Intercept (HK) bought 2,665 Idexx Laboratories shares in Q2 2026, an estimated $1.49M.
  • Idexx Laboratories made up 0.17% of Y-Intercept (HK)'s portfolio in Q2 2026, its #124 holding.
  • Y-Intercept (HK) first reported a position in Idexx Laboratories in Q1 2021 and has held it in 14 quarters since.
  • 235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.